Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Performance Evaluation of the SARS-COV-2 Direct Antigen Rapid Test "DART"

NCT04568356 is registered in ClinicalTrials.gov with E25Bio, Inc. as lead sponsor.

NCT NCT04568356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04568356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Performance Evaluation of the SARS-COV-2 Direct Antigen Rapid Test "DART"
Lead sponsor
E25Bio, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 24, 2020
Completion date
September 24, 2020
Enrollment
200 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sars cov-2